发明名称 AZABENZIMIDAZOLE DERIVATIVES
摘要 The present invention relates to compounds of general formula I,;;wherein the group R1, R2, X, Y and Z are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the AMP-activated protein kinase (AMPK) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
申请公布号 US2016039846(A1) 申请公布日期 2016.02.11
申请号 US201514822268 申请日期 2015.08.10
申请人 Boehringer Ingelheim International GmbH 发明人 LANGKOPF Elke;BLUM Andreas
分类号 C07D519/00;A61K45/06;A61K31/437 主分类号 C07D519/00
代理机构 代理人
主权项 1. A compound of formula I wherein R1 is selected from the group consisting of C3-10-cycloalkyl and heterocyclyl, both optionally substituted with 1 to 3 groups independently selected from HO—, NC—, HO2C—, HO2C—H2C—, C1-4-alkyl, C1-4-alkyl-O—, and HO—C1-4-alkyl-, wherein heterocyclyl denotes a saturated mono-, bi- or spirocyclic ring system having 5 to 10 ring member atoms of which 1 or 2 not vicinal ring members are O atoms; R2 is selected from the group R2-G1 consisting of F, Cl, Br, NC—, C1-4-alkyl, and C1-4-alkyl-O—, wherein any alkyl group and subgroup is optionally substituted with 1 or more F atoms; X is selected from the group X-G1 consisting of a bond, an arylene, and a heteroarylene group, wherein said arylene and heteroarylene groups are optionally substituted with 1 to 3 groups independently selected from F, Cl, Br, I, NC—, HO—, HO2C—, C1-4-alkyl, C1-4-alkyl-O—, F3C—, and F3CO—; Y is selected from the group Y-G1 consisting of an arylene and a heteroarylene group, wherein said arylene and heteroarylene groups are optionally substituted with 1 to 3 groups independently selected from F, Cl, Br, I, NC—, HO—, HO2C—, C1-4-alkyl, C1-4-alkyl-O—, F3C—, and F3CO—; Z is selected from the group Z-G1 consisting of RS(RNRN′N)(O═)S═N—, RS(RNRN′N)(O═)S═N—C1-3-alkyl-, (RN″)N═S(═O)(NRNRN′)—, (RN″)N═S(═O)(NRNRN′)—C1-3-alkyl-, wherein n=1 or 2, RN and RN′ are independently selected from H, C1-4-alkyl, C3-7-cycloalkyl, C3-7-cycloalkyl-C1-3-alkyl-, heterocyclyl, heterocyclyl-C1-3-alkyl-, aryl-, aryl-C1-3-alkyl-, heteroaryl, heteroaryl-C1-3-alkyl-, orRN and RN′ together with the N-atom these groups are attached to form a 4-7 membered saturated monocyclic ring system, wherein one —CH2-ring member optionally is replaced by —NRN′″— or −O—, wherein RN′″ is selected from H, H3C—, H5C2—, and cyclopropyl and wherein the ring system optionally is substituted with 1 to 3 groups independently selected from F, HO—, C1-3-alkyl, C1-3-alkyl-O—, (C1-3-alkyl)2-N—, HO2C—, C1-3-alkyl-C(═O)—, and C1-3-alkyl-S(═O)2—,RN″ is selected from H, NC—, C1-4-alkyl, C1-4-alkyl-C(═O)—, C1-4-alkyl-O—C(═O)—, C1-4-alkyl-N—C(═O)—, C3-7-cycloalkyl, C3-7-cycloalkyl-C1-3-alkyl-, C3-7-heterocyclyl, heterocyclyl-C1-3-alkyl-, aryl, aryl-C1-3-alkyl-, aryl-C(═O)—, aryl-O—C(═O)—, aryl-C1-3-alkyl-O—C(═O)—, aryl-S(═O)2, heteroaryl, and heteroaryl-C1-3-alkyl-, andRS is selected from C1-4-alkyl, C3-7-cycloalkyl, C3-7-cycloalkyl-C1-3-alkyl-, heterocyclyl, heterocyclyl-C1-3-alkyl-, aryl, aryl-C1-3-alkyl-, heteroaryl, heteroaryl-C1-3-alkyl-, and wherein any alkyl, cycloalkyl, and heterocyclyl group mentioned within the definition of RN, RN′, RN″ and RS is optionally substituted with 1 to 3 groups independently selected from F, HO—, C1-3-alkyl-O—, (C1-3-alkyl)2-N—, HO2C—, C1-3-alkyl-C(═O)—, and C1-3-alkyl-S(═O)2—, andwherein any aryl and heteroaryl group mentioned within the definition of and RS is optionally substituted with 1 to 3 groups independently selected from F, Cl, Br, I, HO—, NC—, HO2C—, C1-3-alkyl, C1-3-alkyl-O—, C1-3-alkyl-S(═O)2—, F3C—, and F3CO—, wherein any heterocyclyl group mentioned hereinbefore, if not specified otherwise, denotes a saturated or partially unsaturated monocyclic or bicyclic fused, bridged or spiro group having 5 to 12 ring member atoms of which 4 to 11 ring members are C atoms and 1 to 3 ring members are heteroatoms selected from O, N, NRN″, and S(═O)r with r=0, 1 or 2, with the proviso that no O—O, S—S or S—O bond is formed, wherein 1 CH2 ring member attached to a ring member N atom is optionally replaced by a —C(═O)— group,and wherein RN″ is defined as mentioned hereinbefore; wherein any arylene group mentioned hereinbefore denotes a bivalent aryl group; wherein any heteroarylene group mentioned hereinbefore denotes a bivalent heteroaryl group; wherein any aryl group mentioned hereinbefore, if not specified otherwise, denotes a carbocyclic aromatic monocyclic group containing 6 carbon atoms which may be further fused to a second 5- or 6-membered carbocyclic group which may be aromatic, saturated or unsaturated; wherein any heteroaryl group mentioned hereinbefore, if not specified otherwise, denotes tetrazolyl,a 5-membered heteroaromatic ring containing 1 ring member selected from NRN′″, O and S, or1 N and 1 ring member selected from NRN′″, O and S, or1 NRN′″, O or S and 2 N, wherein RN′″ is defined as mentioned hereinbefore, ora 6-membered heteroaromatic ring containing 1 to 3 N atoms; and wherein in any definition mentioned hereinbefore and if not specified otherwise, any alkyl group or sub-group may be straight-chained or branched, or a salt thereof.
地址 Ingelheim am Rhein DE